Low‐dose thymoglobulin for prevention of chronic graft‐versus‐host disease in transplantation from an HLA ‐matched sibling donor-Reference-Cited by-同舟云学术

Low‐dose thymoglobulin for prevention of chronic graft‐versus‐host disease in transplantation from an HLA ‐matched sibling donor

Published:2021-08-27 Issue:11 Volume:96 Page:1441-1449
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Cho Byung‐Sik¹²^ORCID,Min Gi‐June¹²^ORCID,Park Sung‐Soo¹²,Yoon Seok Yoon³,Park Silvia¹²,Jeon Young‐Woo⁴^ORCID,Shin Seung‐Hwan⁵^ORCID,Yahng Seung‐Ah⁶^ORCID,Yoon Jae‐Ho¹²^ORCID,Lee Sung‐Eun¹²^ORCID,Eom Ki‐Seong¹²,Kim Yoo‐Jin¹²,Min Chang‐Ki¹²^ORCID,Cho Seok‐Goo¹,Kim Dong‐Wook¹²,Lee Jong Wook¹^ORCID,Kim Hee‐Je¹²,Lee Seok¹²

Affiliation:

1. Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

2. Leukemia Research Institute, College of Medicine The Catholic University of Korea Seoul Republic of Korea

3. Department of Hematology, Soon Chun Hyang University Hospital, College of Medicine Soon Chun Hyang University of Korea Seoul Republic of Korea

4. Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

5. Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

6. Department of Hematology, Incheon St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26320

Reference26 articles.

1. Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

2. Current issues in chronic graft-versus-host disease

3. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

4. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

5. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation;Bone Marrow Transplantation;2024-05-21

2. GVHD Prophylaxis;The EBMT Handbook;2024

3. Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades;Transplantation and Cellular Therapy;2023-12

4. Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML;Frontiers in Oncology;2023-11-07

5. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults;Cochrane Database of Systematic Reviews;2023-06-21